Your guide to this week in regulation
Stay up to date with our latest round up of financial regulation.
By: Kantilal Pithia, Sonam Nawani
18 Nov 2026 8 min read

PS20/26 completes the PRA's response to CP14/24 on the large exposures framework. Mandatory substitution for credit risk mitigation applies to every firm from 1 January 2028, with exemptions for funded sovereign collateral and tri-party repo. The trading book excess allowance for third parties falls to 85% of Tier 1 capital for up to 10 business days. Firms can apply for NCLEG permissions from 1 July 2027.
The PRA’s final policy statement (PS20/26) is the second part of its response to CP14/24 on the large exposures framework. Part one was published in July 2025 (PS14/25), finalising lower-impact proposals on use of immovable property to mitigate credit risk, exposures of globally and systemically other systematically important Banks to certain French counterparties and exposure to the deposit guarantee scheme. Part two covers more extensive changes to credit risk mitigation techniques, trading book exposures, and securities financing transactions.
The new PRA large exposures rules aim to limit concentration risk and align the framework more closely with the Basel large exposures standards. Firms will need to make significant changes to their controls and systems ahead of the implementation deadline on 1 January 2028.
Credit risk mitigation (CRM) techniques reflect the most significant change in PS20/26, particularly the introduction of mandatory substitution. Under the current rules, firms can reduce an exposure for collateral or guarantees, and may attribute the covered part to the issuer or guarantor. Once the new rules take effect, firms must attribute it to the collateral issuer or guarantor, subject to limited exemptions. This will help firms and regulators recognise and monitor credit risk concentrations to ensure firms stay within the prescribed limits.
Mandatory substitution will also apply to corporate collateral that’s used as CRM, despite industry concerns that it could affect firms’ willingness to accept corporate bonds and affect repo market liquidity. Similarly, the PRA is applying it to smaller firms, noting that they’re as vulnerable to concentration risk as a larger firm.
The PRA has introduced two new exemptions from large exposures limits under mandatory substitution. The first covers exposures to all issuers of sovereign collateral received as funded credit protection. The original proposal applied only to sovereigns with a 0% risk weight, but the PRA has broadened the exemption to avoid cliff-edge effects if a sovereign is downgraded. However, the exemption does not extend to unfunded credit protection, such as sovereign guarantees. These are exempt only where the sovereign protection provider is assigned a 0% risk weight for credit risk purposes.
The second exemption covers collateral received under tri-party repo, where a tri-party agent facilitates the transaction. As firms have limited day-to-day control over the securities they receive, the PRA exempted these exposures, although firms must still identify and report them. The exemption applies to all firms but should particularly help smaller firms, which are more likely to rely on tri-party agents. The PRA has also exempted indirect exposures to issuers of collateral linked to exempt QCCP-related transactions, which firms must also report.
As per the consultation, PS20/26 confirms the trading book excess allowance for intragroup exposures, with a cut to 85% of Tier 1 capital. If a firm’s non-trading book exposures stay within the usual limits, then it can use the allowance, but it must apply a 100% risk weight to the excess.
The PRA had initially planned to remove the excess allowance for third parties, which had let firms exceed large exposure limits by up to 500% of Tier 1 capital. However, industry feedback noted its importance during periods of market volatility. So, the PRA has opted to retain the allowance, reducing it to 85% of Tier 1 capital for up to 10 business days.
The PRA is replacing the separate non-core large exposures group (NCLEG) permissions for the trading book and non-trading book with a single permission, but the criteria remain the same. Firms with existing permissions should continue to operate them within their existing terms until they expire or are replaced.
CP14/24 proposed that some firms could apply for a higher NCLEG permission, allowing trading book exposures to certain non-UK group entities of up to 250% of Tier 1 capital. Industry feedback showed concerns that 250% wouldn’t absorb the additional exposures due to removing internal models for calculating securities financing transactions (SFTs). As such, the PRA has raised the higher NCLEG limit for trading book exposures only to 350% of Tier 1 capital. It’s also simplified the rule by applying the limit to all firms with a higher NCLEG permission. Firms can apply for the new or higher NCLEG permission from 1 July 2027.
In PS20/26, the PRA removes the option for firms to use internal models to calculate exposure values on securities financing transactions (SFTs). This is because the large exposures framework acts as a backstop to risk-based capital requirements and use of internal models would make concentration measurement depend on firm-specific modelling choices.
However, use of the alternative Financial Collateral Comprehensive Method (FCCM) could show higher exposure without any real change in the underlying risk. To reflect that, the PRA has raised the higher NCLEG limit for trading book exposures.
The PRA hasn’t reviewed the whole large exposures framework against Basel 3.1, which predominantly takes effect on 1 January 2027. But it recognises the overlap between the two and will assess their alignment in 2027, with potential consultations to follow.
Reporting templates won’t change, but the PRA has amended the instructions to clarify how firms should report exposures under mandatory substitution.
PS20/26 reflects significant changes to the PRA large exposures framework and firms have a lot of work ahead to meet the 2028 deadline. First off, firms will need to map their collateral by identifying the issuers and protection providers behind every transaction that uses CRM. Next, firms need to combine direct and indirect exposures to the same counterparty or group to test whether they’re still within the large exposure limit. That’s easier said than done, and many firms will need to update their data collection, monitoring and reporting processes.
Key considerations include:
For further information on the large exposures framework, contact Kantilal Pithia or Sonam Nawani.
The framework is relevant to UK banks and building societies authorised by the PRA, plus investment firms it has designated. It also covers PRA-approved and PRA-designated holding companies, along with other CRR consolidation entities.
Mandatory substitution requires firms that reduce an exposure with eligible credit risk mitigation to count that part against the collateral issuer or protection provider. It is optional now, but compulsory for all firms from 1 January 2028, subject to limited exemptions.
A firm generally cannot hold exposures to one counterparty, or a connected group, above the greater of 25% of its Tier 1 capital and £130 million. There are exemptions covering some intragroup and sovereign exposures, and a time-bound trading book excess allowance.
The framework aims to limit the losses a firm could face if one counterparty, or a connected group, fails suddenly. The Basel Committee's large exposures standards followed the global financial crisis, which showed that firms had not always handled these exposures consistently. They took effect on 1 January 2019.
A firm that breaches a limit in exceptional circumstances can follow the process in Article 396 of the Large Exposures (CRR) Part of the PRA Rulebook. A firm can ask the PRA for time to comply, and the PRA may agree where the circumstances justify it.
Stay up to date with our latest round up of financial regulation.
The partial suspension of the FCA’s redress scheme has not reduced the risk facing motor finance firms. It has extended the timeline, which will leave the outcome unresolved when the next accounts are signed and funding lines come up for renewal. We look at what this means for going concern assessments, access to funding and the actions boards should take now.
FCA updates on pure protection, vulnerability in payments, rising whistleblowing cases, AI-driven investment risks, and T+1 readiness challenges.